Subtopic Deep Dive
FDG PET/CT in Hematological Malignancies
Research Guide
What is FDG PET/CT in Hematological Malignancies?
FDG PET/CT uses 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography for staging, response assessment, and infection detection in hematological malignancies like lymphoma, multiple myeloma, and acute myeloid leukemia.
FDG PET/CT excels in detecting focal lesions in multiple myeloma over 99mTc-MIBI scintigraphy (Fonti et al., 2008, 171 citations). It identifies extramedullary acute myeloid leukemia with high sensitivity (Stölzel et al., 2011, 132 citations). Over 10 papers from 2005-2021, with 237 citations for its role in inflammatory monitoring (Glaudemans et al., 2013).
Why It Matters
FDG PET/CT improves lymphoma staging accuracy and therapy response via Deauville criteria, guiding treatment decisions (Heinz et al., 2017). In multiple myeloma, it detects bone lesions better than alternatives, aiding prognosis (Fonti et al., 2008). For infections in neutropenic patients and myeloma, it localizes fever of unknown origin, reducing empirical antibiotic use (Mahfouz et al., 2005; Glaudemans et al., 2013). This shifts management from skeletal surveys to functional imaging, enhancing survival in hematological disorders (D’Sa et al., 2007).
Key Research Challenges
Differentiating malignancy from inflammation
FDG avidity overlaps in tumors, infections, and therapy-induced marrow changes, complicating interpretation (Glaudemans et al., 2013). Bone marrow activation post-chemotherapy mimics disease (Daldrup-Link et al., 2006). Standardized criteria like Deauville are lymphoma-specific, less validated for myeloma (Fonti et al., 2008).
Detecting diffuse bone marrow disease
FDG PET/CT misses diffuse infiltration unlike 99mTc-MIBI or MRI in myeloma (Fonti et al., 2008). Low sensitivity in early marrow involvement requires hybrid imaging (Murata et al., 2006). Extramedullary sites are detectable but prevalence understudied (Stölzel et al., 2011).
Standardizing infection imaging protocols
FUO in neutropenic hematology patients lacks unified FDG PET/CT guidelines versus white cell scintigraphy (Heinz et al., 2017; Signore et al., 2018). Variable uptake in myeloid sarcoma affects monitoring (Stölzel et al., 2011). Optimal timing post-therapy remains unclear (Mahfouz et al., 2005).
Essential Papers
The Use of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:mrow><mml:mn mathvariant="bold">18</mml:mn></mml:mrow></mml:mrow></mml:math>F-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and Infectious Diseases
Andor W.J.M. Glaudemans, Erik F. J. de Vries, Filippo Galli et al. · 2013 · Clinical and Developmental Immunology · 237 citations
FDG-PET, combined with CT, is nowadays getting more and more relevant for the diagnosis of several infectious and inflammatory diseases and particularly for therapy monitoring. Thus, this paper giv...
Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
Werner Heinz, Dieter Buchheidt, Maximilian Christopeit et al. · 2017 · Annals of Hematology · 172 citations
<sup>18</sup>F-FDG PET/CT, <sup>99m</sup>Tc-MIBI, and MRI in Evaluation of Patients with Multiple Myeloma
Rosa Fonti, Barbara Salvatore, Mario Quarantelli et al. · 2008 · Journal of Nuclear Medicine · 171 citations
In whole-body analysis, (18)F-FDG PET/CT performed better than (99m)Tc-MIBI in the detection of focal lesions, whereas (99m)Tc-MIBI was superior in the visualization of diffuse disease. In the spin...
Clinical indications, image acquisition and data interpretation for white blood cells and anti-granulocyte monoclonal antibody scintigraphy: an EANM procedural guideline
Alberto Signore, François Jamar, Ora Israel et al. · 2018 · European Journal of Nuclear Medicine and Molecular Imaging · 169 citations
These guidelines should be applied by all nuclear medicine centers in favor of a highly reproducible standardized practice.
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation
Massimiliano Casali, Chiara Lauri, Corinna Altini et al. · 2021 · Clinical and Translational Imaging · 161 citations
MR imaging of therapy-induced changes of bone marrow
Heike E. Daldrup‐Link, Tobias D. Henning, Thomas M. Link · 2006 · European Radiology · 145 citations
18F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia
Friedrich Stölzel, Christoph Röllig, J. Radke et al. · 2011 · Haematologica · 132 citations
Myeloid sarcoma in acute myeloid leukemia has been clearly defined by the World Health Organization but studies regarding the prevalence and the prognostic impact of extramedullary acute myeloid le...
Reading Guide
Foundational Papers
Start with Glaudemans et al. (2013, 237 citations) for FDG PET/CT in infections/inflammation basics; Fonti et al. (2008, 171 citations) for myeloma comparisons; Stölzel et al. (2011, 132 citations) for AML detection rationale.
Recent Advances
Study Casali et al. (2021, 161 citations) for updated imaging guidelines; Heinz et al. (2017, 172 citations) for FUO protocols; Signore et al. (2018, 169 citations) for scintigraphy standards.
Core Methods
Core techniques: SUV measurements (Murata et al., 2006), Deauville scoring (Heinz et al., 2017), hybrid PET/CT for extramedullary sites (Stölzel et al., 2011), versus MRI/ scintigraphy (Fonti et al., 2008).
How PapersFlow Helps You Research FDG PET/CT in Hematological Malignancies
Discover & Search
Research Agent uses searchPapers and exaSearch to find meta-analyses on FDG PET/CT sensitivity in lymphoma staging, pulling 250M+ OpenAlex papers filtered by 'FDG PET/CT hematological malignancies'. citationGraph reveals connections from Glaudemans et al. (2013, 237 citations) to infection monitoring studies. findSimilarPapers expands from Fonti et al. (2008) to myeloma lesion detection.
Analyze & Verify
Analysis Agent applies readPaperContent to extract Deauville criteria validation from Heinz et al. (2017), then verifyResponse with CoVe chain-of-verification flags contradictions in FDG vs. MRI sensitivity (Fonti et al., 2008). runPythonAnalysis computes meta-analysis stats on citation data via pandas, with GRADE grading for evidence quality in extramedullary AML detection (Stölzel et al., 2011).
Synthesize & Write
Synthesis Agent detects gaps in diffuse marrow imaging protocols via contradiction flagging across Glaudemans (2013) and Murata (2006). Writing Agent uses latexEditText for response criteria tables, latexSyncCitations to link 10+ papers, and latexCompile for publication-ready reviews. exportMermaid visualizes FDG vs. scintigraphy comparison flows.
Use Cases
"Run meta-analysis on FDG PET/CT sensitivity for extramedullary AML from Stölzel 2011 and similar papers."
Research Agent → searchPapers('extramedullary AML FDG PET') → runPythonAnalysis(pandas meta-analysis on sensitivities, matplotlib ROC curves) → GRADE grading → structured CSV export.
"Write LaTeX review comparing FDG PET/CT to MRI in multiple myeloma lesion detection."
Synthesis Agent → gap detection on Fonti 2008 → Writing Agent → latexEditText(draft sections) → latexSyncCitations(10 papers) → latexCompile(PDF) → exportBibtex.
"Find code for FDG uptake quantification in bone marrow from hematology PET papers."
Research Agent → paperExtractUrls(Murata 2006) → paperFindGithubRepo → githubRepoInspect(Python scripts) → runPythonAnalysis(reproduce SUV correlations).
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(50+ FDG hematology papers) → citationGraph → DeepScan(7-step analysis with CoVe checkpoints on Fonti 2008 vs. MRI) → GRADE report. DeepScan verifies infection protocols: readPaperContent(Heinz 2017) → verifyResponse → runPythonAnalysis(uptake stats). Theorizer generates hypotheses on novel tracers from Glaudemans 2013 gaps.
Frequently Asked Questions
What is FDG PET/CT in hematological malignancies?
FDG PET/CT combines 18F-FDG positron emission tomography with CT for staging lymphomas, detecting myeloma lesions, and assessing AML extramedullary disease (Fonti et al., 2008; Stölzel et al., 2011).
What are key methods in FDG PET/CT for hematology?
Methods include Deauville criteria for response, SUV quantification for marrow uptake, and hybrid imaging for FUO (Heinz et al., 2017; Murata et al., 2006; Glaudemans et al., 2013).
What are the most cited papers?
Glaudemans et al. (2013, 237 citations) on infection monitoring; Fonti et al. (2008, 171 citations) on myeloma; Stölzel et al. (2011, 132 citations) on AML.
What open problems exist?
Challenges include inflammation mimicry, diffuse disease detection, and protocol standardization for infections (Daldrup-Link et al., 2006; Signore et al., 2018; Mahfouz et al., 2005).
Research Hematological disorders and diagnostics with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching FDG PET/CT in Hematological Malignancies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers